Home Regeneron Pharms Downgraded by Brean Murray
 

Keywords :   


Regeneron Pharms Downgraded by Brean Murray

2013-01-18 05:36:43| Biotech - Topix.net

A number of other firms have also recently commented on REGN. Analysts at Robert W. Baird raised their price target on shares of Regeneron Pharms from $176.00 to $205.00 in a research note to investors on Tuesday.

Tags: murray downgraded brean regeneron

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Public Advisory Number 2
02.11Subtropical Storm Patty Forecast Advisory Number 2
02.11Subtropical Storm Patty Update Statement
More »